Robert MacLaren, Professor of Ophthalmology at the University of Oxford, is an outstanding, internationally recognised, clinician-scientist in this field. He has undertaken pioneering research dedicated to finding new treatments, particularly using stem cell-based approaches, gene therapy and electronic retinas, for patients with incurable retinal diseases. He has been able to successfully link academia, industry and the NHS with his work with Retina Implant AG in Germany. This led to the successful implantation of the first electronic retina in the UK and, more recently, he performed the world’s first robotic eye operation in Oxford. Professor MacLaren has also set up gene therapy trials internationally in Canada, USA and Germany.
FellowBack to directory listing
Professor Robert MacLaren FMedSci
Professor of Ophthalmology
Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences
University of Oxford
Developing new treatments for blindness using gene therapy, stem cell treatments and electronic devices.Section committee elected by
Surgery, anaesthesia, oncology, clinical pathologies, radiology, oral health, ophthalmology, reproductive health